Sign Up to like & get
recommendations!
0
Published in 2019 at "Trends in molecular medicine"
DOI: 10.1016/j.molmed.2019.07.001
Abstract: Inter- and intra-patient molecular heterogeneity of primary and metastatic prostate cancer (PCa) confers variable clinical outcome and poses a formidable challenge in disease management. High-throughput integrative genomics and functional approaches have untangled the complexity involved…
read more here.
Keywords:
ets fusion;
molecular underpinnings;
fusion negative;
prostate cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-250236
Abstract: In this report, we describe the case of an adolescent male with an unusual case of fusion-negative, paratesticular alveolar rhabdomyosarcoma who presented with spontaneous tumour lysis syndrome and diffuse bony metastases throughout the axial and…
read more here.
Keywords:
bony metastases;
rhabdomyosarcoma;
diffuse bony;
fusion negative ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2023.1061570
Abstract: Rhabdomyosarcoma (RMS) is a pediatric myogenic soft tissue sarcoma that includes fusion-positive (FP) and fusion-negative (FN) molecular subtypes. FP-RMS expresses PAX3-FOXO1 fusion protein and often shows dismal prognosis. FN-RMS shows cytogenetic abnormalities and frequently harbors…
read more here.
Keywords:
fusion;
spermine;
dna damage;
fusion negative ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Genes"
DOI: 10.3390/genes12101500
Abstract: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents and accounts for approximately 2% of soft tissue sarcomas in adults. It is subcategorized into distinct subtypes based on histological features and…
read more here.
Keywords:
stratification;
model systems;
fusion negative;
pax fusion ... See more keywords